Targeting of drugs and nanoparticles to tumors
Open Access
- 15 March 2010
- journal article
- review article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 188 (6), 759-768
- https://doi.org/10.1083/jcb.200910104
Abstract
The various types of cells that comprise the tumor mass all carry molecular markers that are not expressed or are expressed at much lower levels in normal cells. These differentially expressed molecules can be used as docking sites to concentrate drug conjugates and nanoparticles at tumors. Specific markers in tumor vessels are particularly well suited for targeting because molecules at the surface of blood vessels are readily accessible to circulating compounds. The increased concentration of a drug in the site of disease made possible by targeted delivery can be used to increase efficacy, reduce side effects, or achieve some of both. We review the recent advances in this delivery approach with a focus on the use of molecular markers of tumor vasculature as the primary target and nanoparticles as the delivery vehicle.Keywords
This publication has 101 references indexed in Scilit:
- Tissue-Penetrating Delivery of Compounds and Nanoparticles into TumorsCancer Cell, 2009
- Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearanceBiomaterials, 2009
- SERS‐Coded Gold Nanorods as a Multifunctional Platform for Densely Multiplexed Near‐Infrared Imaging and Photothermal HeatingAdvanced Materials, 2009
- Targeting of albumin-embedded paclitaxel nanoparticles to tumorsNanomedicine: Nanotechnology, Biology and Medicine, 2009
- Systematic Surface Engineering of Magnetic Nanoworms for In vivo Tumor TargetingSmall, 2009
- A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRIBioconjugate Chemistry, 2008
- Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearanceAdvanced Drug Delivery Reviews, 2008
- Protease‐Triggered Unveiling of Bioactive NanoparticlesSmall, 2008
- Genes that Distinguish Physiological and Pathological AngiogenesisCancer Cell, 2007
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996